Sartorius Stedim Biotech S.A. (DIM.PA)
Makes lab equipment and materials that help companies develop and manufacture drugs and vaccines.
170.00+0.04%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-1.0%
The outlook
DIM.PA trades at 170, currently below both its 50- and 200-day moving averages after a modest gain today. Analysts lean bullish with an average target implying roughly 35% upside from here, though the stock sits in the lower portion of its 52-week range. The trailing P/E of 56.5 reflects elevated valuations relative to current earnings.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 14 analysts
Price trendBelow its 50- & 200-day averages
52-week range27% of the way from its 52-week low to high
Price targetAvg target +35% vs current price
Analyst price target
~12-month · 14 analysts229.79average target+35.2% vs now
Now 170.00
Low 208.00High 262.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$16.54B
52-wk high
224.00
52-wk low
150.00
50-day avg
175.43
200-day avg
184.59
Trailing P/E
56.5